2026-06-14T05:05:08Zhttps://repisalud.isciii.es/rest/oai/request
oai:repisalud.isciii.es:20.500.12105/48192025-03-27T07:35:06Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19608
Repisalud author Deblonde, Jessika author Sasse, André author Amo, Julia del author Burns, Fiona M author Delpech, Valerie author Cowan, Susan author Levoy, Michele author Keith, Lilana author Pharris, Anastasia author Amato-Gauci, Andrew J author Noori, Teymur 2017-09-04T16:29:30Z 2017-09-04T16:29:30Z 2015-12-10 BMC Public Health. 2015; 15: 1228 10.1186/s12889-015-2571-y 1471-2458 BMC Public Health 26654427 http://hdl.handle.net/20.500.12105/4819 BACKGROUND: In the European Union/European Economic Area (EU/EEA), migrants from high-endemic countries are disproportionately affected by HIV. Between 2007 and 2012, migrants represented 39 % of reported HIV cases. There is growing evidence that a significant proportion of HIV acquisition among migrant populations occurs after their arrival in Europe. DISCUSSION: Migrants are confronted with multiple risk factors that shape patterns of population HIV susceptibility and vulnerability, which simultaneously affect HIV transmission. Undocumented migrants incur additional risks for contracting HIV due to limited access to adequate health care services, protection and justice, alongside insecure housing and employment conditions. All EU/EEA countries have ratified a number of international and regional human rights instruments that enshrine access to health care as a human right that should be available to everyone without discrimination. From a clinical and public health perspective, early HIV care and treatment is associated with viral suppression, improved health outcomes and reductions in transmission risks. A current challenge of the HIV epidemic is to reach the highest proportion of overall viral suppression among people living with HIV in order to impact on HIV transmission. Although the majority of EU/EEA countries regard migrants as an important sub-population for their national responses to HIV, and despite the overwhelming evidence of the individual and public health benefits associated with HIV care and treatment, a significant number of EU/EEA countries do not provide antiretroviral treatment to undocumented migrants. HIV transmission dynamics in migrant populations depend on the respective weight of all risk and vulnerability factors to which they are exposed, which act together in a synergistic way. People who are not linked to HIV care will continue to unwillingly contribute to the on-going transmission of HIV. Following the recommendations of the European Union Agency for Fundamental Rights, ensuring access to HIV-care for all sub-populations, including undocumented migrants, would fulfil the human rights of those populations and also strengthen the control of HIV incidence among those not currently able to access HIV care. eng HIV infection Migrants Europe Antiretroviral treatment Access to health care Restricted access to antiretroviral treatment for undocumented migrants: a bottle neck to control the HIV epidemic in the EU/EEA research article URL https://repisalud.isciii.es/bitstreams/9b50bf09-8924-4bfc-a57a-1b36bc2fa44b/download File MD5 1b3aa0340b7876d9edd5da17fce79fb9 755821 application/pdf RestrictedAccessToAntiretroviral_2015.pdf URL https://repisalud.isciii.es/bitstreams/d93076fa-b826-4a79-970b-e4b127ca6980/download File MD5 afa3cf130ed4ecb3cabe308104ae5df3 71462 text/plain 12889_2015_Article_2571.pdf.txt URL https://repisalud.isciii.es/bitstreams/de124d0a-f760-46ca-ad4e-cd543a2d8495/download File MD5 afa3cf130ed4ecb3cabe308104ae5df3 71462 text/plain RestrictedAccessToAntiretroviral_2015.pdf.txt URL https://repisalud.isciii.es/bitstreams/1100ee5d-27f9-4c10-afa6-a5e26e9a92f8/download File MD5 afa3cf130ed4ecb3cabe308104ae5df3 71462 text/plain RestrictedAccessToAntiretroviral_2015.pdf.txt